Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Condition(s):Stage I Renal Cell Cancer; Stage II Renal Cell CancerLast Updated:June 9, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Stage I Renal Cell Cancer; Stage II Renal Cell CancerLast Updated:June 9, 2023Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:May 9, 2022Recruiting
Condition(s):Potentially Resectable Stage II/IIIa NSCLCLast Updated:September 26, 2019Recruiting
Condition(s):Clear Cell Renal Cell Carcinoma; Kidney Cancer; Advanced Renal Cell CarcinomaLast Updated:December 5, 2023Recruiting
Condition(s):Advanced Renal Cell CarcinomaLast Updated:November 13, 2023Recruiting
Condition(s):Metastatic Clear Cell Renal Cell CarcinomaLast Updated:November 18, 2023Recruiting
Condition(s):Advanced Clear Cell Renal Carcinoma (Ccrcc); Papillary Renal Cell Carcinoma (Prcc)Last Updated:March 28, 2024Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:May 16, 2023Recruiting
Condition(s):Brain Metastases; Renal Cell CarcinomaLast Updated:October 27, 2023Recruiting
Condition(s):Metastatic Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v8; Unresectable Renal Cell CarcinomaLast Updated:March 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.